# A Refined Approach to Isolate Interneurons for High-Validity Epigenetic Studies in Human Brain Tissue

**Authors:** Ariel Cariaga-Martínez, Kilian Jesús Gutierrez, Ignacio Regidor, Marta Del Álamo, Jerónimo Saiz-Ruiz, Raúl Alelú-Paz

PMC · DOI: 10.3390/mps8030061 · Methods and Protocols · 2025-06-05

## TL;DR

This paper introduces a new method to isolate specific brain cells for detailed epigenetic studies, which could help understand disorders like schizophrenia and autism.

## Contribution

A practical and reproducible protocol for isolating GAD-positive interneurons from human brain tissue for epigenetic analysis.

## Key findings

- A protocol was developed to isolate GAD-positive interneurons from human brain samples suitable for epigenetic analysis.
- The isolated cells were validated against interneurons derived from human iPSCs to ensure specificity.
- The method enables high-quality DNA extraction for methylation-specific PCR and other epigenetic studies.

## Abstract

Epigenetic research has made notable progress in recent years, yet our ability to explore the human brain at a cellular level remains limited. One of the main obstacles has been the difficulty of isolating specific neuronal populations from postmortem tissue—particularly interneurons, which play a central role in many psychiatric disorders. In this study, we present a practical and reproducible protocol for isolating GAD-positive interneurons from human brain samples. We isolate permeabilized cell-like structures suitable for downstream epigenetic analysis. To ensure specificity, we validated the isolated cells by comparing them with interneurons derived from human iPSCs. This approach allows for high-quality DNA extraction suitable for downstream epigenetic analysis, including methylation-specific PCR. By targeting a well-defined neuronal subtype, our method provides a solid foundation for studying the molecular changes associated with disorders such as schizophrenia and autism. This protocol opens new doors for cell-specific investigations in brain tissue, a step forward in understanding how epigenetic mechanisms contribute to neuropsychiatric pathophysiology.

## Linked entities

- **Proteins:** GAD1 (glutamate decarboxylase 1)
- **Diseases:** schizophrenia (MONDO:0005090), autism (MONDO:0005260)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** GAD1 (glutamate decarboxylase 1) [NCBI Gene 2571] {aka CPSQ1, DEE89, GAD, GAD-67, SCP}
- **Diseases:** autism (MESH:D001321), neuropsychiatric (MESH:C000631768), schizophrenia (MESH:D012559), psychiatric disorders (MESH:D001523)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12196513/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12196513/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12196513/full.md

---
Source: https://tomesphere.com/paper/PMC12196513